A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Cancer
Breast Cancer

Results
Download
Print

Study results

LPS BO28407 KAITLIN Interim Results March 2021 English (PDF, 0.9 MB)

LPS BO28407 KAITLIN Final Results February 2022 English (PDF, 0.9 MB)

LPS BO28407 KAITLIN Final Results February 2022 German (PDF, 1.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Study results

LPS BO28407 KAITLIN Interim Results March 2021 English (PDF, 0.9 MB)

LPS BO28407 KAITLIN Final Results February 2022 English (PDF, 0.9 MB)

LPS BO28407 KAITLIN Final Results February 2022 German (PDF, 1.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

For the latest version of this information please go to www.forpatients.roche.com